Adolescent major depressive disorder is a highly prevalent and debilitating condition, yet objective and generalizable neurofunctional signatures remain elusive. Existing neuroimaging approaches largely rely on resting-state fMRI, or controlled tasks often lack ecological validity and generalizable signatures of depression-related neural dysfunctions. This study proposes a Visual–Affective Decoding (VAD) framework integrating cross-subject visual and affective decoding from whole-brain fMRI acquired during naturalistic movie viewing. A dual-pathway anomaly detection model trained exclusively on healthy controls establishes normative brain function and identifies MDD through deviations from this norm. In 200 adolescents (112 MDD, 88 HC), VAD achieved an AUC of 0.87, 95.56% sensitivity, 83.89% accuracy, and 72.22% specificity. Using the same anomaly threshold, it generalized to an independent external adolescent cohort (70 MDD, 68 HC), achieving an AUC of 0.81 with an accuracy of 75.36%, supporting its cross-site generalizability. VAD further revealed interpretable neurofunctional signatures, including blunted emotional reactivity, attenuated visual representation, and affective patterns consistent with emotional rumination. Region-level contribution analyses identified dissociable visual- and affective-sensitive cortical regions, consistent with dysfunctions in visual, default-mode, salience, and higher-order associative networks. These findings demonstrate that VAD provides objective, interpretable, and generalizable neurofunctional signatures for adolescent depression diagnosis and clinically relevant biomarker development.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: